{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:41:14Z","timestamp":1759534874985,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.tox.2007.09.032","type":"journal-article","created":{"date-parts":[[2007,10,9]],"date-time":"2007-10-09T08:32:14Z","timestamp":1191918734000},"page":"66-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride"],"prefix":"10.1016","volume":"243","author":[{"given":"Fl\u00e1vio Jos\u00e9 Dutra de","family":"Moura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pushkin Pires","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rog\u00e9rio de Souza","family":"Furtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Imaculada","family":"Muniz-Junqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel Paulo Russomano","family":"Veiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2007.09.032_bib1","first-page":"29","article-title":"Deaths in visceral leishmaniasis (Kala-azar) during treatment","volume":"51","author":"Ahasan","year":"1996","journal-title":"Med. J. Malaysia"},{"key":"10.1016\/j.tox.2007.09.032_bib2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/infdis\/163.4.853","article-title":"Tumor necrosis factor (cachectin) in human visceral leishmaniasis","volume":"163","author":"Barral-Netto","year":"1991","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tox.2007.09.032_bib3","doi-asserted-by":"crossref","first-page":"E702","DOI":"10.1152\/ajpendo.00147.2006","article-title":"Pentoxifylline inhibits Ca2+-dependent and ATP proteasome-dependent proteolysis in skeletal muscle from acutely diabetic rats","volume":"292","author":"Baviera","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tox.2007.09.032_bib4","first-page":"1180","article-title":"Nephrite azotemique au cours du traitement par l\u2019antimoine d\u2019un cas de leishmaniose viscerale infantile","volume":"41","author":"Charlas","year":"1962","journal-title":"Maroc. M\u00e9d."},{"key":"10.1016\/j.tox.2007.09.032_bib5","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.1985.34.702","article-title":"Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate)","volume":"34","author":"Chulay","year":"1985","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.tox.2007.09.032_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0035-9203(88)90267-2","article-title":"Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stiboglucanate or meglumine antimoniate","volume":"82","author":"Chulay","year":"1988","journal-title":"Trans. R. Soc. Trop. M\u00e9d. Hyg."},{"key":"10.1016\/j.tox.2007.09.032_bib7","unstructured":"Coelho, V.N.P.D., 2003. Influ\u00eancia do tratamento, in vitro de fag\u00f3citos humanos e murinos com antimoniato de meglumina sobre a fagocitose, produ\u00e7\u00e3o de radicais de oxig\u00eanio e nitrog\u00eanio e fator de necrose tumoral-\u03b1. Thesis. Universidade de Bras\u00edlia."},{"key":"10.1016\/j.tox.2007.09.032_bib8","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1128\/iai.60.11.4504-4509.1992","article-title":"Effect of ingested pentoxifylline on neutrophils superoxide anion production","volume":"60","author":"Crouch","year":"1992","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tox.2007.09.032_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1590\/S0036-46651990000400003","article-title":"Renal changes caused by pentavalent antimonial (Glucantime) hypersensitivity in American tegumentary leishmaniasis. Report of a case","volume":"32","author":"Cuce","year":"1990","journal-title":"Rev. Inst. Med. Trop. S\u00e3o Paulo"},{"key":"10.1016\/j.tox.2007.09.032_bib10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000079121","article-title":"Pentoxifylline ameliorates renal tumor necrosis factor expression, sodium retention, and renal hypertrophy in diabetic rats","volume":"24","author":"DiPetrillo","year":"2004","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.tox.2007.09.032_bib11","first-page":"192","article-title":"Pentoxifylline suppression of tumor necrosis factor gene transcription","volume":"110","author":"Doherty","year":"1991","journal-title":"Surgery"},{"key":"10.1016\/j.tox.2007.09.032_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00005392-199907000-00068","article-title":"Review article: the role of tumor necrosis factor in renal ischemia\u2014reperfusion injury","volume":"162","author":"Donnahoo","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/j.tox.2007.09.032_bib13","first-page":"567","article-title":"Pentavalent antimonial inhibition of the osmotic effect of oxytocin on the isolated toad bladder","volume":"18","author":"Gagliardi","year":"1985","journal-title":"Brazilian J. Med. Biol. Res."},{"key":"10.1016\/j.tox.2007.09.032_bib14","unstructured":"Gagliardi, A.R.T., 1986. Efeito inibit\u00f3rio do antimonial pentavalente sobre a a\u00e7\u00e3o permeabilizante dos pept\u00eddeos neurohipofis\u00e1rios na bexiga isolada do sapo. Thesis. Universidade de Bras\u00edlia."},{"key":"10.1016\/j.tox.2007.09.032_bib15","first-page":"449","article-title":"Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats","volume":"70","author":"G\u00f3mez-Chiarri","year":"1994","journal-title":"Lab. Invest."},{"key":"10.1016\/j.tox.2007.09.032_bib16","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0140-6736(85)91245-0","article-title":"Nephrotoxicity of pentavalent antimonials","volume":"9","author":"Jolliffe","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.tox.2007.09.032_bib17","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1081\/JDI-120026026","article-title":"Beneficial effect of pentoxifylline on cisplatin-induced acute renal failure in rabbits","volume":"25","author":"Kim","year":"2003","journal-title":"Ren. Fail."},{"key":"10.1016\/j.tox.2007.09.032_bib18","first-page":"41","article-title":"Pentoxifylline-a pharmacodynamically versatile agent","volume":"2","author":"Kriska","year":"1998","journal-title":"Slovakofarma Revue VIII"},{"key":"10.1016\/j.tox.2007.09.032_bib19","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1128\/IAI.70.12.6589-6591.2002","article-title":"Antimonial therapy induces circulating proinflamatory cytokines in patients with cutaneous leishmaniasis","volume":"70","author":"Kocyigit","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tox.2007.09.032_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1110(96)90003-2","article-title":"Mutagenicity, carcinogenicity and teratogenicity of antimony compounds","volume":"366","author":"Leonard","year":"1996","journal-title":"Mutat. Res."},{"issue":"Suppl.","key":"10.1016\/j.tox.2007.09.032_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00005344-199500252-00005","article-title":"Cytokines, phagocytes, and pentoxifylline","volume":"25","author":"Mandell","year":"1995","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.tox.2007.09.032_bib22","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4269\/ajtmh.1985.34.710","article-title":"High continuous antimony therapy in two patients with unresponsive mucosal leishmaniasis","volume":"34","author":"Marsden","year":"1985","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.tox.2007.09.032_bib23","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1681\/ASN.V86861","article-title":"Transcriptional regulation of aquaporin-2 water channel gene by cAMP","volume":"8","author":"Matsumura","year":"1997","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tox.2007.09.032_bib24","first-page":"262","article-title":"Pentoxifylline in vivo down-regulates the release of IL-1\u03b2, IL-6, IL-8 and tumour necrosis factor-\u03b1 by human peripheral blood mononuclear cells","volume":"83","author":"Neuner","year":"1994","journal-title":"Immunology"},{"key":"10.1016\/j.tox.2007.09.032_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0169-4758(93)90231-4","article-title":"Practical progress and new drugs for changing patterns of leishmaniasis","volume":"9","author":"Olliaro","year":"1993","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.tox.2007.09.032_bib26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drup.2004.07.002","article-title":"Leishmaniasis: drugs in the clinic, resistance and new developments","volume":"7","author":"Ouellette","year":"2004","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.tox.2007.09.032_bib27","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1172\/JCI200215606","article-title":"TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity","volume":"110","author":"Ramesh","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tox.2007.09.032_bib28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0140-6736(80)90120-8","article-title":"Renal clearance of pentavalent antimony (sodium stibogluconate)","volume":"2","author":"Rees","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.tox.2007.09.032_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/S0036-46651999000100007","article-title":"Nephrotoxicity attribute to meglumine antimoniate (glucantime) in the treatment of generalized cutaneous leishmaniasis","volume":"41","author":"Rodrigues","year":"1999","journal-title":"Rev. Inst. Med. Trop. S\u00e3o Paulo"},{"key":"10.1016\/j.tox.2007.09.032_bib30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1590\/S0037-86822000000400009","article-title":"Comparative study between sodium stibogluconate BP 88\u00ae and meglumine antimoniate in cutaneous leishmaniasis treatment. II. Biochemical and cardiac toxicity","volume":"33","author":"Saldanha","year":"2000","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.tox.2007.09.032_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1590\/S0036-46651996000200005","article-title":"Plasma levels of tumor necrosis factor-\u03b1 in patients with visceral leishmaniasis (Kala-azar). Association with activity of the disease and clinical remission following antimonial therapy","volume":"38","author":"Salom\u00e3o","year":"1996","journal-title":"Rev. Inst. Med. Trop. S\u00e3o Paulo"},{"key":"10.1016\/j.tox.2007.09.032_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1590\/S0037-86821997000600003","article-title":"Avalia\u00e7\u00e3o da toler\u00e2ncia e nefrotoxicidade do antimonial pentavalente administrado na dose de 40mg SbV\/kg\/dia,de 12\/12h,por 30 dias na forma cut\u00e2neo-mucosa de Leishmaniose","volume":"30","author":"Sampaio","year":"1997","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.tox.2007.09.032_bib33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0369-8114(02)00323-1","article-title":"Nephroprotective effects of pentoxifylline in experimental myoglobinuric acute renal failure","volume":"50","author":"Savic","year":"2002","journal-title":"Pathol. Biol. (Paris)"},{"key":"10.1016\/j.tox.2007.09.032_bib34","first-page":"520","article-title":"Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity","volume":"78","author":"Semmler","year":"1993","journal-title":"Immunology"},{"key":"10.1016\/j.tox.2007.09.032_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0262-1746(83)90085-9","article-title":"Pentoxifylline enhances formation of prostacyclin from rat vascular and renal tissue","volume":"12","author":"Sinzinger","year":"1983","journal-title":"Prostaglandins Leukot. M\u00e9d."},{"key":"10.1016\/j.tox.2007.09.032_bib36","first-page":"1169","article-title":"Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis","volume":"16","author":"Timoshanko","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tox.2007.09.032_bib37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/taap.1995.1006","article-title":"Antimony-induced oxidative stress and toxicity in cultured cardiac myocytes","volume":"130","author":"Tirmenstein","year":"1995","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2007.09.032_bib38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0300-483X(97)03628-7","article-title":"Antimony-induced alterations in thiol homeostasis and adenine nucleotide status in cultured cardiac myocytes","volume":"119","author":"Tirmenstein","year":"1997","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2007.09.032_bib39","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(83)90595-0","article-title":"Renal tubular dysfunction in patients with muco-cutaneous leishmaniasis treated with pentavalent antimonials","volume":"2","author":"Veiga","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.tox.2007.09.032_bib40","first-page":"293","article-title":"Renal function in patients with muco-cutaneous leishmaniasis treated with pentavalent antimonials","volume":"27","author":"Veiga","year":"1985","journal-title":"Rev. Inst. Med. Trop. S\u00e3o Paulo"},{"key":"10.1016\/j.tox.2007.09.032_bib41","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1590\/S0036-46651990000400012","article-title":"Pentavalent antimonial nephrotoxicity in the rat","volume":"32","author":"Veiga","year":"1990","journal-title":"Rev. Inst. Med. Trop. S\u00e3o Paulo"},{"key":"10.1016\/j.tox.2007.09.032_bib42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2165\/00003495-198734010-00003","article-title":"Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy","volume":"34","author":"Ward","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/j.tox.2007.09.032_bib43","unstructured":"World Health Organization: Leishmaniasis. http:\/\/www.who.int\/leishmaniasis\/disease_epidemiology\/en\/index.html (assessed in 25\/03\/2007)."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X07006695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X07006695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:00:34Z","timestamp":1759532434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X07006695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":43,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0300483X07006695"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2007.09.032","relation":{},"ISSN":["0300-483X"],"issn-type":[{"type":"print","value":"0300-483X"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2007.09.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}